Johns Hopkins HIV Guide
Lopinavir/Ritonavir
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals in adults and pediatric patients (14 days and older).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 30, 2016
Citation
Pham, Paul A, and John G Bartlett. "Lopinavir/Ritonavir." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir.
Pham PA, Bartlett JG. Lopinavir/Ritonavir. Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir. Accessed June 2, 2023.
Pham, P. A., & Bartlett, J. G. (2016). Lopinavir/Ritonavir. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir
Pham PA, Bartlett JG. Lopinavir/Ritonavir [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2023 June 02]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lopinavir/Ritonavir
ID - 545123
A1 - Pham,Paul,Pharm.D.
AU - Bartlett,John,M.D.
Y1 - 2016/03/30/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
